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Abstract
Heterotrimeric guanine nucleotide–binding proteins (G proteins) are positioned at the top of many
signal transduction pathways. The G protein α subunit is composed of two domains, one that
resembles Ras and another that is composed entirely of α helices. Historically, most attention has
focused on the Ras-like domain, but emerging evidence reveals that the helical domain is an active
participant in G protein signaling.
Introduction
Most good stories have a strong central character, but they often work with a close confidant
or collaborator. Sherlock Holmes relied on Doctor Watson, whose contributions might have
escaped the attention of the casual observer. The same could be said of many proteins,
protein subunits, and protein domains.
A trusty comrade is always of use; and a chronicler still more so.
—from The Adventures of Sherlock Holmes
Heterotrimeric guanine nucleotide–binding proteins (G proteins) play a central role in signal
transduction. Various chemical and environmental signals bind to cell-surface receptors that
activate G proteins, which are composed of an α subunit and an obligate βγdimer. The Gα
subunits in particular are part of a large and diverse family whose members include the
proto-oncogene Ras and the bacterial elongation factor Tu (EF-Tu). In general, the activity
of these proteins is dictated by cycles of guanosine triphosphate (GTP) binding and
hydrolysis (Fig. 1). Exchange of GTP for guanosine diphosphate (GDP) initiates G protein
activation, whereas GTP hydrolysis terminates the signal. Both steps are tightly regulated by
accessory proteins. Cell-surface receptors serve as guanine nucleotide exchange factors
(GEFs). Conversely, regulator of G protein signaling (RGS) proteins act as guanosine
triphosphatase (GTPase)–activating proteins (GAPs). At least one effector enzyme can
likewise serve as a GAP (1, 2). Additional proteins can serve as guanine nucleotide
dissociation inhibitors (GDIs).
Although G proteins are composed of three subunits, it is the α subunit that does much of
the heavy lifting. Upon receptor activation, the α subunit undergoes profound
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conformational changes, liberates the G protein βγsubunits, activates downstream effectors,
and binds to the RGS protein. The α subunit is in turn composed of two domains, one that
resembles Ras and another that is composed entirely of α helices. For years the Ras-like
domain has received almost all of the attention. Here, we focus on newly appreciated
functions of the helical domain.
“Data! Data! Data!” he cried impatiently. “I can’t make bricks without clay.”
—from The Adventure of the Copper Beeches
Crystal Structure Data Reveal a Displacement of the G Protein Helical
Domain
Three-dimensional (3D) structures of Gα, alone and in complex with Gβγor other binding
partners, have provided critical insights into how these molecular “switches” operate. The
first crystal structures of Gα revealed substantial changes in three segments known as
Switch I, Switch II, and Switch III (3). All three switches lie within the Ras domain,
although Switch I (which is also called linker 2) connects the Ras-like domain with the
helical domain. These switch regions are primary contact sites for, and dictate the
association with, the G βγ subunits (Switch II), RGS proteins, and effectors One exception
to the rule is Gαt, for which the helical domain alone binds to an effector enzyme, cyclic
guanosine monophosphate (cGMP) phosphodiesterase, and which does so with equivalent
apparent affinity and subtype selectivity to that of the full-length Gα protein (4, 5).
All of the available crystal structures indicate that nucleotide binding occurs primarily
within the Ras-like domain. Bound GTP or GDP is sequestered between the Ras-like
domain and the helical domain; thus, exchange of one nucleotide for the other must depend
on the separation of the two domains (Fig. 1). Indeed, early studies revealed that each
domain can exist separately and, when recombined, the free exchange of GDP and GTP is
slowed (6). Paradoxically, the rate of dissociation of GDP from native Gαi and G αs is
greater than that from Ras, which possesses no helical domain. The rapid nucleotide
exchange rate of G αrelative to that of Ras is likely a result of the low affinity of Gα-GDP
for Mg2+ (7). On the other hand, the helical domain may help to stabilize nucleotide binding
in the absence of coordination of Mg2+ (8).
Further findings uncovered additional functions for the helical domain. One insight comes
from the determination of the crystal structure of the G protein αsubunit from the plant
Arabidopsis thaliana (AtGPA1). The plant G protein represents an interesting
counterexample to G proteins in animals, because Arabidopsis appears to lack a canonical G
protein–coupled receptor (GPCR). Instead, AtGPA1 activates itself at a rate that is two to
three orders of magnitude faster than those of its animal counterparts (9). Detailed structural,
biophysical, and molecular dynamics analyses indicate that the helical domain in AtGPA1 is
more disordered and dynamic than those in other known G proteins. Could the flexibility
within the helical domain account for its spontaneous activation property? Indeed, domain-
swapping experiments confirmed that it is the helical domain of AtGPA1 that accounts for
its higher basal activity (10).
A major breakthrough came in the form of a crystal structure of the animal G protein Gs in
complex with an agonist-occupied β2 adrenergic receptor (Fig. 1) (11). That work confirmed
interactions that were long suspected but never demonstrated directly. Specifically, it
revealed that direct interactions occurred between the receptor and the N- and C-terminal
segments of Gαs but that there were no direct contacts between the receptor and the
Gβγsubunits. Within Gα, the largest conformational change caused by the receptor was in
the Ras-like domain and in particular the α5 helix, which was rotated and displaced toward
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the core of the receptor. Previous studies with various approaches had predicted an
important role for the α5 helix in the activation of G proteins by receptors (12, 13).
Whereas previous structures of Gα were solved in the presence of GDP, GTP analogs, or the
transition state analog GDP-AlF4−, attempts to isolate Gα in the absence of nucleotide
proved difficult (14). The receptor-bound complex, in contrast, is nucleotide-free. That
structure—caught in the act of activation—reveals a massive displacement of the helical
domain away from the Ras-like domain (Fig. 1). Thus, upon receptor binding, the two
domains dissociate, exposing the nucleotide-binding pocket. It remains uncertain whether
domain dissociation is the cause or consequence of nucleotide release. Nevertheless, the
observed changes reveal a plausible mechanism for nucleotide exchange, whereby the two
domains open in a clamshell motion to liberate GDP and accommodate GTP. This
mechanism has since been corroborated with various complementary biophysical methods.
We must look for consistency. Where there is a want of it we must suspect
deception.
—from The Problem of Thor Bridge
Experimental Validation of New Structural Models
A crystal structure is a model (and a static model at that), and any model requires
experimental validation. In the case of the receptor–G protein complex, corroboration was
swift and persuasive. Even before seeing the receptor and G protein complex, Van Eps et al.
had obtained evidence in support of key features of the structure. The authors employed
double electron-electron resonance spectroscopy to measure the change in distance between
chemical probes positioned on the Ras-like and helical domains of G αi. With this method,
they observed a large (up to 20 Å) increase in the distance between domains, compatible
with the release of nucleotide after receptor activation (15). In addition, they observed broad
distance distributions for several labeling pairs, indicating the existence of multiple
conformations in dynamic equilibrium. The distances observed in the nucleotide-free state
corresponded to minor populations observed for the nucleotide-bound state. Thus, receptor
activation appears to shift the equilibrium from a closed state to an open state(s).
A second strategy entailed measurements of deuterium exchange. By changing the solvent
from H2O to D2O, deuterons are incorporated into the amide positions accessible to the
solvent. The pattern of deuterium labeling provides information about protein tertiary
structure. With this method, it was established that receptor binding promotes an increase in
solvent accessibility within the nucleotide-binding site of Gα and throughout the interface
between the helical and Ras-like domains. In comparison, there is little exchange within the
core of the helical domain itself, which suggests that it remains mostly intact and folded
(16). Thus, the deuterium-exchange studies confirmed that the interface between the Ras-
like and helical domains becomes exposed after receptor activation.
Finally, a third study used single-particle EM (EM) to visualize the complex of receptor and
G protein. With this approach, it was demonstrated that the helical domain occupies various
positions relative to the Ras-like domain, receptor, and Gβγ. The helical domain was visible
in only about a third of the particles (17), however, and in those instances the position of the
helical domain with respect to the Ras domain was similar to that seen in the structures of
Gαs-GTPγS and Gαi-GDP/Gβγ(18, 19), but entirely different from the receptor-Gαs
crystal complex. These results indicated that the helical domain undergoes a transition from
a conformationally stabilized (inactivated) state to a more flexible (activated) state that is
invisible to EM.
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Thus, a consistent picture emerges from structural and biophysical analysis. These
investigations showed that the Ras-like and helical domains undergo a domain separation
compatible with the release of nucleotide. But is this motion recapitulated in cells?
Resonance energy transfer analysis has been used to monitor the dissociation of G protein
domains and subunits in response to receptor activation. Early studies reported a loss of
resonance energy transfer between probes in the Gα subunit and probes in either Gβ (20) or
Gγ (21). Given the placement of the probes at sites within the helical domain of Gα, and
with the benefit of new structural information, it is possible that the loss of interaction was
actually due to the movement of the helical domain away from the Ras-like domain and
Gβγ (22).
The position of the helical domain in the crystal structure is likely to represent just one of
several possible conformations available to the protein. Moreover, Switch domains I and II
are inherently flexible and, in some cases, could not be modeled because of a lack of
electron density. In studies of the “cytosolic” GEF, Ric-8A, the nucleotide-free G αi
displayed virtually no thermal transition upon heating, which suggests the loss of stable
tertiary interactions in the nucleotide-free state (23). Similarly, we have speculated that
intrinsic flexibility accounts for the ability of the plant G protein to “self-activate,” whereas
flexibility in the animal G proteins is regulated by the agonist-bound receptor (10).
Aside from G proteins, there is growing evidence that a substantial proportion of cellular
proteins contain segments that are flexible or unstructured in solution. Such “intrinsically
disordered proteins” carry out important biological functions that may require the absence of
a specific 3D structure (24). Disorder could confer function by increasing the surface area
available to binding partners, including enzymes that impart a posttranslational
modification. For example, it has been demonstrated that intrinsically disordered proteins
are considerably more likely than ordered regions to be phosphorylated in vivo (25).
Singularity is almost invariably a clue.
—from The Boscombe Valley Mystery
Posttranslational Modifications That Target the Helical Domain
Although rare, there are examples of posttranslational modifications within the G protein
helical domain. One early paper reported the phosphorylation of a site within the helical
domain of Gα2 from Dictyostelium discoideum (Ser113, between the αB and αC helices)
(26). Mammalian Src phosphorylates Gαt-GDP in vitro, and the site of phosphorylation was
later mapped to the helical domain (Tyr114, between αD and αE) (27). Phosphorylation by
Src is likely to be functionally important, given that phosphorylation improves receptor-
catalyzed activation of the G protein (26). It remains to be determined if and how these
phosphorylation events affect G protein signaling in cells (28).
Much work has centered on the phosphorylation and ubiquitination of Gpa1, a G protein α
subunit from the yeast Saccharomyces cerevisiae. Gpa1 is a particularly interesting example
because it undergoes monoubiquitination as well as the more common polyubiquitination
(that is, the formation of ubiquitin-ubiquitin conjugates). Work spanning the past decade has
revealed that mono- and polyubiquitination are mediated by distinct enzymes (29, 30), that
these modifications have distinct consequences for Gpa1 trafficking and function (31), and
that polyubiquitination is dynamically regulated through phosphorylation (32). All of these
modifications occur within the helical domain of Gpa1, and in particular within a unique
109-residue insert close to the αB helix (32, 33). Thus, the helical domain of Gpa1 binds to
a number of modifying proteins, including the protein kinase(s) and at least two ubiquitin
ligases (29, 30, 32).
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Skill is fine, and genius is splendid, but the right contacts are more valuable than
either.
—Arthur Conan Doyle, Sr.
Contact Sites in the Helical Domain Contribute to Protein-Binding
Specificity
All G protein subtypes exhibit a high degree of sequence similarity. Sequence conservation
is greatest within the Ras-like domain, particularly the switch regions, and weakest in the
helical domain. This distinction has led to speculation that the helical domain contributes to
subtype-selective interactions with at least some binding partners. Here, we highlight
examples of contacts with the helical domain that have been documented through change-of-
function mutations or crystal structures of G proteins and their binding partners.
Crystal structures of various Gαand RGS pairs have revealed helical domain contacts,
including complexes of Gαo with RGS16, G αi1 with RGS4, and G αi3 with RGS8 and
RGS10 (34, 35). In each case, the contact sites are few in number (two to three amino acid
residues in each protein) but heterogeneous in sequence and thus likely to contribute to Gα -
binding selectivity. In support of this idea, domain-swapping experiments revealed that it is
the helical domain of Gαt that confers binding selectivity to RGS9 (36). Another prominent
example is the receptor kinase GRK2, which has an RGS domain that binds to selected Gα
protein subtypes, although it lacks appreciable GAP activity (37). GRK2 binds well to Gα16,
as well as to chimeric proteins that contain the helical domain of Gα16 and the Ras-like
domain of Gαq, but not to the reciprocal chimeras (38). Through site-directed mutagenesis
studies, the helical domain interactions were subsequently mapped to a higher resolution
(39).
Particularly extensive contacts with the helical domain have been documented for two of the
more unusual RGS proteins, RGS14 and p115RhoGEF (Fig. 1). RGS14 is one of a handful
of RGS family members that contain a GoLoco motif, in addition to a canonical RGS core
domain. Whereas RGS proteins promote GTP hydrolysis, GoLoco proteins interact
specifically with GDP-bound Gα proteins and act to slow nucleotide exchange. Thus,
RGS14 functions as both a GAP and a GDI. Crystallographic analysis revealed extensive
contacts between the GoLoco fragment of RGS14 and portions of Gαi1-GDP, including the
αA and αB helices of the helical domain, the bound nucleotide, and Switch I of the Ras-like
domain (40). The helical domain interactions appear to alter the conformation of Gα,
causing the αB-αC loop to become displaced from the Ras-like domain. The contact sites
within the helical domain also appear to be important for Gα binding specificity. RGS14 is a
GDI for Gαi1 but not Gαo; however, it is evident from the crystal structure that the contact
sites within the Ras-like domain are conserved in both Gα subtypes. Whereas a chimera
consisting of the Ras-like domain of Gαo and the helical domain of Gαi1 was responsive to
the GoLoco peptide, the reciprocal chimera was not (40).
An especially striking example of a helical domain–binding protein comes from a crystal
structure of the RGS domain of p115RhoGEF in complex with Gα13 or a hybrid Gα
assembled from Gα13 and Gαi3 (41, 42). p115RhoGEF is a GAP for Gα13 and also serves
as a GEF for Rho family GTPases; activation of Gα13 stimulates Rho GEF activity (43, 44).
Thus, the protein is both an inhibitor and an effector for Gα, directly coupling activation of
Gα13 to the activation of Rho. The GAP domain of p115RhoGEF has only weak sequence
similarity to other RGS proteins, however, and the structure of the p115RhoGEF-Gα
complex indicated some major differences compared with those of other RGS-Gα
complexes. Specifically, the p115RhoGEFGα structure revealed regions N-terminal to the
RGS core domain that form extensive contacts with the helical domain. Moreover, whereas
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the structures of Gα13 and Gαi are largely superimposable, the helical domain contact sites
are distinct. These contacts are evidently important for GAP activity, as was demonstrated
by domain-swapping experiments (41, 42).
Thus, it appears that the helical domain may confer binding selectivity for a number of RGS
proteins and their homologs. There is also limited evidence that the helical domain is an
active participant in signal transmission. One of the original crystal structures of Gαi bound
to GDP and Gβγ revealed several differences when compared with that of Gαi-GTPγS
(45). Aside from the usual changes in Switch I, II, and III, a fourth segment within the
helical domain was unwound by approximately one turn, thereby extending the αB-αC
loop. The authors dubbed the αB-α C loop “Switch IV.” These observations raise the
possibility of a nucleotide-dependent conformational change in the helical domain. The
crystal structures of RGS14 GoLoco and p115Rho-GEF also revealed modest
conformational changes within the helical domain of their cognate Gα, particularly within
the αB and αC helices. Moreover, molecular dynamics simulations have pointed to
unexpected differences in inter- and intradomain motion when comparing the animal and
plant G proteins, Gαi and AtGPA1. Subsequent experimental analysis of chimeric proteins
established that the αA helix is almost entirely responsible for the >100-fold faster rate of
nucleotide exchange exhibited by AtGPA1 (46). Thus, changes in the helical domain, even
changes that are far from the nucleotide-binding pocket, can have profound effects on the
nucleotide-binding function of the G protein.
You know my methods, Watson. There was not one of them which I did not apply
to the inquiry. And it ended by my discovering traces, but very different ones from
those which I had expected.
—from The Crooked Man
Opportunities for New Pharmacology
What do these observations mean for pharmacology? Roughly half of all drugs work, either
directly or indirectly, on GPCRs. These include receptors for opioids, angiotensin II,
epinephrine, histamine, and serotonin. The crystal structure of a receptor in complex with a
G protein will no doubt provide new opportunities for receptor pharmacology. Likewise, the
Gα helical domain has features that could be useful in drug interactions, including potential
binding pockets and a conformational flexibility that could accommodate the binding of
small molecules, features that are not afforded the “small” G proteins. With recent advances,
it is evident that emerging opportunities are not limited to receptors but also include the G
protein and the growing number of G protein–binding proteins that rely on the helical
domain for their activity.
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The role of the helical domain during the cycle of G protein activation and inactivation.
Images of the indicated crystal structures at different stages of G protein activation. Shown
are the G protein Ras-like domain (gray), the G protein helical domain (red), the Go-Loco
peptide (blue), an adenylyl cyclase fragment (AC, green and cyan), and the RGS fragment
from p115RhoGEF (rgRGS, yellow). For reference, the Ras-like domains were aligned and
held to the same relative position in each image. In the resting state, the helical domain
covers the bound guanine nucleotide. (Inset) Overlay of the helical domain from three
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different structures shows how it is displaced (relative to the fixed Ras-like domain) during
the binding of receptor (red), Gβγ(pink), and RGS protein (burgundy).
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